Find the investors funding Health Series C rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Isomorphic Labs raises $5 billion in Series C to build out clinical development - XenoSpectrum
Isomorphic Labs is an AI-driven drug discovery company. It aims to accelerate the drug discovery and development process using artificial intelligence. This Series C funding will support the company's efforts to advance its clinical development pipeline.
Isomorphic Labs raises $5 billion in Series C to build out clinical development XenoSpectrum
| Nov 19, 2026 | Aevius | $22.0M | — | — |
| Nov 18, 2026 | Celosia Therapeutics | $2.0M | Grant | Australia |
| Nov 17, 2026 | Mass General Brigham | $22.0M | Seed | United States |
| Nov 17, 2026 | Treat | $3.0M | — | — |
You just read who funded Isomorphic Labs. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.